{"id":"pp6m-injection-dose-1","safety":{"commonSideEffects":[{"rate":null,"effect":"Menstrual irregularities (amenorrhea, spotting, breakthrough bleeding)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Weight changes"},{"rate":null,"effect":"Mood changes"}]},"_chembl":{"chemblId":"CHEMBL2108760","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"PP6M (progestin-only injection) is a hormonal contraceptive administered as an intramuscular injection designed to provide extended contraceptive coverage. It works by releasing a synthetic progestin that suppresses the luteinizing hormone surge necessary for ovulation, thickens cervical mucus to impede sperm transport, and alters the endometrium to prevent implantation. The formulation is engineered for prolonged drug release, providing contraceptive efficacy over an extended dosing interval.","oneSentence":"PP6M is a long-acting injectable contraceptive that prevents pregnancy through hormonal suppression of ovulation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:29:46.163Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Contraception in women of reproductive age"}]},"trialDetails":[{"nctId":"NCT03345342","phase":"PHASE3","title":"A Study of Paliperidone Palmitate 6-Month Formulation","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2017-11-20","conditions":"Schizophrenia","enrollment":841},{"nctId":"NCT04072575","phase":"PHASE3","title":"A Study of Paliperidone Palmitate 6-Month Formulation","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2019-09-19","conditions":"Schizophrenia","enrollment":178}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["R092670"],"phase":"phase_3","status":"active","brandName":"PP6M injection Dose 1","genericName":"PP6M injection Dose 1","companyName":"Janssen Research & Development, LLC","companyId":"janssen-research-development-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"PP6M is a long-acting injectable contraceptive that prevents pregnancy through hormonal suppression of ovulation. Used for Contraception in women of reproductive age.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}